Semaglutide is a powerful weight-loss medication that works by mimicking the hormone GLP-1 (glucagon-like peptide-1) to regulate appetite and promote feelings of fullness. It reduces hunger, slows digestion, and helps control cravings, leading to decreased calorie intake. Weight loss effects are often noticeable within the first week, with significant progress achieved by week 20, making it an effective option for those seeking sustained and meaningful reductions in body weight.

Tirzepatide is a groundbreaking medication that combines the effects of two hormones, GLP-1 and GIP (glucose-dependent insulinotropic polypeptide), to support rapid weight loss and blood sugar control. It works by reducing appetite, enhancing feelings of fullness, and improving metabolic processes. Many users report noticeable results within the first few weeks, with significant weight loss often achieved in as little as 12–16 weeks, making it one of the fastest-acting options for those managing obesity.